2751 - 2760 of 4301 Drugs
Tivorbex (indomethacin capsules)
Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate acute pain in adults.
Uplizna (inebilizumab-cdon injection)
Uplizna (inebilizumab-cdon) is a CD19-directed cytolytic antibody used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
Infed (iron dextran)
INFeD (iron dextran) Injection is a form of the mineral iron used to treat iron deficiencies and iron deficiency anemia.
Infergen (interferon alfacon-1)
Infergen (interferon alfacon-1) is a synthetic type-I interferon made from human proteins and is used to treat chronic hepatitis C.
Truseltiq (infigratinib capsules)
Truseltiq (infigratinib) is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.
Inflectra (infliximab-dyyb intravenous injection)
Inflectra (infliximab-dyyb) for Injection is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of Crohn's disease, pediatric Crohn's disease, ulcerative colitis, rheumatoid arthritis (in combination with methotrexate), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Remicade (infliximab)
Remicade (infliximab) is a chimeric IgG1k monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn's disease, and ankylosing spondylitis. Remicade is also used to treat severe or disabling plaque psoriasis (raised, silvery flaking of the skin). Remicade is often used when other medicines have not been effective. Remicade blocks the action of a protein in your body called tumor necrosis factor-alpha (TNF-alpha).
Renflexis (infliximab-abda injection)
Renflexis (infliximab-abda) for Injection is a tumor necrosis factor (TNF) blocker indicated for Crohn's disease, pediatric Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Ixifi (infliximab-qbtx for injection, for intravenous use)
Ixifi (infliximab-qbtx) for Injection is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of Crohn's disease, pediatric Crohn's disease, ulcerative colitis (UC), rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.